Showing 690 – 700 of 1305 results
-
Prevail Therapeutics Inc Initiation
William Blair & Company initiated research coverage of Prevail Therapeutics Inc. (PRVL $11.90), a clinical-stage company developing adeno-associated virus (AAV) gene therapies for neurodegenerative disorders of the central nervous system.
-
Brandon Lower
View biography for Brandon Lower, Managing Director, Head of Financial Sponsors Group.
-
James Dunham
View biography for James Dunham, Business Development, Financial Institutional and National Accounts.
-
Cissie Citardi
View biography for Cissie Citardi, general counsel.
-
Amino Health Transaction
William Blair acted as the exclusive financial advisor to Amino Health in arranging debt and equity capital to refinance its existing indebtedness and support its continued growth.
-
Kristina Blaschek
View biography for Kristina Blaschek, Director of Business and Technology Solutions.
-
William Blair Investment Management Named a 2023 Best Place to Work
For the 11th year, William Blair Investment Management was named a Best Place to Work in Money Management by Pensions & Investments magazine.
-
Butterfly Network Inc Initiation
William Blair initiated research coverage of Butterfly Network, Inc. (BFLY $2.55), a pioneer of digital ultrasound technology that is disrupting conventional medical imaging with its proprietary Ultrasound-on-Chip technology.
-
Korea Stewardship Code
William Blair is a signatory to the Korea Stewardship Code.
-
Braming Named to Forbes 50 Over 50 List
Stephanie Braming, CFA, partner, global head of William Blair Investment Management, has been named to Forbes’ fourth annual 50 Over 50 list, which is dedicated to spotlighting women across industries.